Operating Income Summary of Revvity, Inc.

Revvity, Inc.'s latest annual operating income in 2023 was 300.56 Million USD , down -59.53% from previous year.
Revvity, Inc.'s latest quarterly operating income in 2024 Q2 was 101.52 Million USD , up 130.13% from previous quarter.
Revvity, Inc. reported an annual operating income of 742.69 Million USD in 2022, down -44.26% from previous year.
Revvity, Inc. reported an annual operating income of 1.33 Billion USD in 2021, up 36.15% from previous year.
Revvity, Inc. reported a quarterly operating income of 100.52 Million USD for 2024 Q3, down -3.32% from previous quarter.
Revvity, Inc. reported a quarterly operating income of 101.52 Million USD for 2024 Q2, up 130.13% from previous quarter.

Annual Operating Income Chart of Revvity, Inc. (2023 - 1989)

Historical Annual Operating Income of Revvity, Inc. (2023 - 1989)

Year	Operating Income	Operating Income Growth
2023	300.56 Million USD	-59.53%
2022	742.69 Million USD	-44.26%
2021	1.33 Billion USD	36.15%
2020	978.58 Million USD	170.35%
2019	361.97 Million USD	11.76%
2018	323.88 Million USD	6.26%
2017	304.8 Million USD	7.68%
2016	283.06 Million USD	-1.07%
2015	286.13 Million USD	35.77%
2014	210.74 Million USD	-3.08%
2013	217.44 Million USD	11.13%
2012	195.66 Million USD	118.13%
2011	89.7 Million USD	-41.6%
2010	153.6 Million USD	4.06%
2009	147.61 Million USD	-23.5%
2008	192.97 Million USD	14.75%
2007	168.16 Million USD	9.62%
2006	153.4 Million USD	-34.52%
2005	234.28 Million USD	32.31%
2004	177.07 Million USD	-3.72%
2003	183.9 Million USD	49.07%
2002	123.36 Million USD	-37.56%
2001	197.58 Million USD	7.37%
2000	184.02 Million USD	76.27%
1999	104.4 Million USD	229.34%
1998	31.7 Million USD	-73.93%
1997	121.6 Million USD	38.65%
1996	87.7 Million USD	6.05%
1995	82.7 Million USD	-36.97%
1994	131.2 Million USD	8.61%
1993	120.8 Million USD	-1.95%
1992	123.2 Million USD	-1.6%
1991	125.2 Million USD	16.25%
1990	107.7 Million USD	9.45%
1989	98.4 Million USD	0.31%

Year	Operating Income	Operating Income Growth
2024 Q1	44.11 Million USD	-42.82%
2024 Q3	100.52 Million USD	-3.32%
2024 Q2	101.52 Million USD	130.13%
2023 Q4	77.15 Million USD	11.46%
2023 FY	300.56 Million USD	-59.53%
2023 Q3	69.22 Million USD	-11.31%
2023 Q1	49.41 Million USD	-64.06%
2023 Q2	78.05 Million USD	57.98%
2022 Q3	134.45 Million USD	-52.88%
2022 Q4	137.46 Million USD	2.24%
2022 Q2	285.35 Million USD	11.97%
2022 Q1	254.84 Million USD	-17.83%
2022 FY	742.69 Million USD	-44.26%
2021 Q1	467.77 Million USD	-8.32%
2021 Q3	221.97 Million USD	-33.24%
2021 FY	1.33 Billion USD	36.15%
2021 Q4	310.14 Million USD	39.72%
2021 Q2	332.48 Million USD	-28.92%
2020 Q2	175.63 Million USD	293.09%
2020 Q1	44.68 Million USD	-67.68%
2020 Q3	248 Million USD	41.2%
2020 Q4	510.25 Million USD	105.74%
2020 FY	978.58 Million USD	170.35%
2019 Q1	53.33 Million USD	-53.9%
2019 Q3	78.66 Million USD	-14.25%
2019 Q4	138.24 Million USD	75.75%
2019 FY	361.97 Million USD	11.76%
2019 Q2	91.73 Million USD	72.01%
2018 Q4	115.68 Million USD	44.24%
2018 Q3	80.2 Million USD	-8.93%
2018 FY	323.88 Million USD	6.26%
2018 Q2	88.06 Million USD	120.52%
2018 Q1	39.93 Million USD	-59.01%
2017 Q2	75.99 Million USD	47.34%
2017 Q4	97.42 Million USD	33.63%
2017 FY	304.8 Million USD	7.68%
2017 Q1	51.57 Million USD	-35.88%
2017 Q3	72.9 Million USD	-4.07%
2016 Q4	80.44 Million USD	-0.97%
2016 FY	283.06 Million USD	-1.07%
2016 Q3	81.22 Million USD	14.1%
2016 Q1	68.76 Million USD	-18.83%
2016 Q2	71.19 Million USD	3.53%
2015 Q1	57.38 Million USD	87.72%
2015 Q4	84.72 Million USD	11.63%
2015 Q2	68.13 Million USD	18.73%
2015 Q3	75.89 Million USD	11.4%
2015 FY	286.13 Million USD	35.77%
2014 Q3	58.77 Million USD	-15.6%
2014 Q4	30.56 Million USD	-47.99%
2014 Q2	69.63 Million USD	37.26%
2014 Q1	50.73 Million USD	-40.09%
2014 FY	210.74 Million USD	-3.08%
2013 FY	217.44 Million USD	11.13%
2013 Q3	57.19 Million USD	21.46%
2013 Q4	84.68 Million USD	48.05%
2013 Q1	35.9 Million USD	-23.89%
2013 Q2	47.09 Million USD	31.17%
2012 Q4	47.16 Million USD	9.14%
2012 FY	195.66 Million USD	118.13%
2012 Q1	36.38 Million USD	680.81%
2012 Q2	49.78 Million USD	36.85%
2012 Q3	43.21 Million USD	-13.19%
2011 Q2	37.49 Million USD	-4.71%
2011 FY	89.7 Million USD	-41.6%
2011 Q4	-6.26 Million USD	-118.31%
2011 Q3	34.2 Million USD	-8.75%
2011 Q1	39.34 Million USD	-18.58%
2010 Q1	39.44 Million USD	-31.4%
2010 Q2	42.62 Million USD	8.04%
2010 Q3	41.41 Million USD	-2.82%
2010 FY	153.6 Million USD	4.06%
2010 Q4	48.32 Million USD	16.67%
2009 Q4	57.5 Million USD	47.73%
2009 Q1	25.74 Million USD	-70.1%
2009 FY	147.61 Million USD	-23.5%
2009 Q2	37.94 Million USD	47.38%
2009 Q3	38.92 Million USD	2.59%
2008 FY	192.97 Million USD	14.75%
2008 Q1	36.38 Million USD	-28.78%
2008 Q2	47.03 Million USD	29.28%
2008 Q3	39.43 Million USD	-16.15%
2008 Q4	86.1 Million USD	118.32%
2007 FY	168.16 Million USD	9.62%
2007 Q2	48.1 Million USD	30.91%
2007 Q1	36.74 Million USD	-29.61%
2007 Q3	45.83 Million USD	-4.71%
2007 Q4	51.08 Million USD	11.45%
2006 Q4	52.2 Million USD	42.96%
2006 Q2	35.69 Million USD	23.11%
2006 Q1	28.99 Million USD	-74.62%
2006 FY	153.4 Million USD	-34.52%
2006 Q3	36.51 Million USD	2.3%
2005 FY	234.28 Million USD	32.31%
2005 Q4	114.22 Million USD	180.63%
2005 Q3	40.7 Million USD	-30.25%
2005 Q2	58.35 Million USD	63.94%
2005 Q1	35.59 Million USD	-44.57%
2004 Q1	27.53 Million USD	-74.68%
2004 Q2	39.15 Million USD	42.17%
2004 Q3	42.89 Million USD	9.56%
2004 FY	177.07 Million USD	-3.72%
2004 Q4	64.21 Million USD	49.71%
2003 Q1	32.14 Million USD	-53.66%
2003 Q4	108.74 Million USD	220.62%
2003 Q3	33.91 Million USD	44.58%
2003 Q2	23.45 Million USD	-27.02%
2003 FY	183.9 Million USD	49.07%
2002 Q2	19.85 Million USD	292.09%
2002 Q4	69.36 Million USD	315.48%
2002 FY	123.36 Million USD	-37.56%
2002 Q3	16.69 Million USD	-15.93%
2002 Q1	-10.33 Million USD	-112.72%
2001 Q3	33.3 Million USD	-37.87%
2001 Q4	81.27 Million USD	144.06%
2001 FY	197.58 Million USD	7.37%
2001 Q1	51.19 Million USD	2.76%
2001 Q2	53.59 Million USD	4.7%
2000 Q1	38.59 Million USD	-31.21%
2000 FY	184.02 Million USD	76.27%
2000 Q4	49.81 Million USD	-42.16%
2000 Q3	86.13 Million USD	96.87%
2000 Q2	43.74 Million USD	13.36%
1999 Q2	37.1 Million USD	43.8%
1999 Q1	25.8 Million USD	-30.08%
1999 FY	104.4 Million USD	229.34%
1999 Q4	56.1 Million USD	6.65%
1999 Q3	52.6 Million USD	41.78%
1998 Q1	18.8 Million USD	-43.03%
1998 Q2	-8.8 Million USD	-146.81%
1998 Q4	36.9 Million USD	82.67%
1998 Q3	20.2 Million USD	329.55%
1998 FY	31.7 Million USD	-73.93%
1997 Q2	48.8 Million USD	197.56%
1997 FY	121.6 Million USD	38.65%
1997 Q4	33 Million USD	61.76%
1997 Q3	20.4 Million USD	-58.2%
1997 Q1	16.4 Million USD	-29.31%
1996 Q2	21.4 Million USD	7.54%
1996 Q1	19.9 Million USD	-27.64%
1996 FY	87.7 Million USD	6.05%
1996 Q4	23.2 Million USD	0.0%
1996 Q3	23.2 Million USD	8.41%
1995 FY	82.7 Million USD	-36.97%
1995 Q4	27.5 Million USD	43.23%
1995 Q3	19.2 Million USD	-6.34%
1995 Q2	20.5 Million USD	30.57%
1995 Q1	15.7 Million USD	-90.24%
1994 FY	131.2 Million USD	8.61%
1994 Q4	160.9 Million USD	387.84%
1994 Q2	25.5 Million USD	16.44%
1994 Q1	21.9 Million USD	-37.25%
1994 Q3	-55.9 Million USD	-319.22%
1993 Q2	31.4 Million USD	6.8%
1993 Q3	25.1 Million USD	-20.06%
1993 Q4	34.9 Million USD	39.04%
1993 FY	120.8 Million USD	-1.95%
1993 Q1	29.4 Million USD	-2.97%
1992 Q4	30.3 Million USD	-5.9%
1992 FY	123.2 Million USD	-1.6%
1992 Q1	27.2 Million USD	-25.27%
1992 Q3	32.2 Million USD	-3.88%
1992 Q2	33.5 Million USD	23.16%
1991 Q1	25.1 Million USD	-21.32%
1991 Q3	33.3 Million USD	9.54%
1991 Q4	36.4 Million USD	9.31%
1991 FY	125.2 Million USD	16.25%
1991 Q2	30.4 Million USD	21.12%
1990 Q1	22.8 Million USD	-32.94%
1990 Q2	26.4 Million USD	15.79%
1990 FY	107.7 Million USD	9.45%
1990 Q3	26.5 Million USD	0.38%
1990 Q4	31.9 Million USD	20.38%
1989 FY	98.4 Million USD	0.31%
1989 Q1	390.9 Million USD	142.4%
1989 Q2	25.8 Million USD	-93.4%
1989 Q3	21 Million USD	-18.6%
1989 Q4	34 Million USD	61.9%

Peer Operating Income Comparison of Revvity, Inc.

Name	Operating Income	Operating Income Difference
Agilent Technologies, Inc.	1.35 Billion USD	77.736%
Charles River Laboratories International, Inc.	617.26 Million USD	51.307%
Quest Diagnostics Incorporated	1.26 Billion USD	76.184%
Danaher Corporation	5.2 Billion USD	94.222%
Enzo Biochem, Inc.	-9.81 Million USD	3161.648%
IQVIA Holdings Inc.	1.97 Billion USD	84.797%
Laboratory Corporation of America Holdings	725.6 Million USD	58.577%
Mettler-Toledo International Inc.	1.15 Billion USD	73.907%
Qiagen N.V.	445.24 Million USD	32.495%
Thermo Fisher Scientific Inc.	6.85 Billion USD	95.618%
Waters Corporation	817.67 Million USD	63.242%

Global Stocks Search

Revvity, Inc. (RVTY)

Operating Income Summary of Revvity, Inc.

Annual Operating Income Chart of Revvity, Inc. (2023 - 1989)

Historical Annual Operating Income of Revvity, Inc. (2023 - 1989)

Peer Operating Income Comparison of Revvity, Inc.